Awarded

BEVACIZUMAB [25 MG/ML; 100 MG/ 4 ML; CONC P/A SOL P/A PERFUSÃO; FRS] + BEVACIZUMAB [25 MG/ML; 400 MG/ 16 ML; CONC P/A SOL P/A PERFUSÃO; FRS]

Original language: Portuguese

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Contract value
€22,870
Bids received
4
Published
9 Nov 2026
Awarded
21 Oct 2026
Contract start
21 Oct 2026
Contract end
3 Nov 2027estimated

More awards from this buyer